Zydus Lifesciences shares rose 7% following USFDA's final approval to market Dasatinib tablets across multiple strengths. The ...

The uptick in Zydus Life share price came after the company announced that it has received final approval from the USFDA to ...

Dasatinib is the generic version of Sprycel® tablets, a medication widely used for treating Ph+, chronic myeloid leukemia ...

Zydus Lifesciences Ltd is quoting at Rs 906.2, up 2.11% on the day as on 12:49 IST on the NSE. The stock is down 7.22% in last one year as compared to a 0.19% fall in NIFTY and a 6.32% fall in the ...

Zydus Lifesciences is developing a combination vaccine targeting shigellosis and typhoid, with support from the Gates ...

The company launched ANVIMO (Letermovir), a breakthrough in the prevention of Cytomegalovirus (CMV) infection for haematopoietic stem cell transplant (HSCT) and kidney transplant patients. ANVIMO will ...

Zydus Lifesciences launches ANVIMO, a breakthrough drug for preventing Cytomegalovirus infection in transplant patients, ...

Zydus Lifesciences Ltd on Wednesday (March 5) said it has received final approval from the United States Food and Drug ...

Veteran Bollywood actor Anupam Kher is set to bring the inspiring life story of Padma Bhushan Pankaj Patel, the renowned ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Zydus Lifesciences introduces ANVIMO, a cost-effective medication for preventing CMV infection in transplant patients, ...

Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.